Humacyte Inc (HUMA)
4.68
-0.06
(-1.27%)
USD |
NASDAQ |
Jan 08, 16:00
4.61
-0.07
(-1.50%)
After-Hours: 05:21
Humacyte SG&A Expense (Quarterly): 7.307M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Bio-Path Holdings Inc | 1.317M |
| Aadi Bioscience Inc | 7.186M |
| PACS Group Inc | 144.38M |
| NovaBay Pharmaceuticals Inc | 2.65M |
| Palatin Technologies Inc | 2.021M |